Thymoxamine and airways obstruction.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000402:Airway Obstruction / Q000188:drug therapy*; D001249:Asthma / Q000188:drug therapy; D006801:Humans; D013948:Moxisylyte / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*; D013729:Terpenes / Q000627:therapeutic use*; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D013565:Sympatholytics; D013729:Terpenes; D013948:Moxisylyte